LONDON (ShareCast) - Losses soared to £111m last year at pharmacy and GP services supplier Assura, as it took a massive hit on its property assets.
Trading losses for the year to March came in lower than expectations at £2.7m
compared with a loss of £5.4m in the prior period due to better than expected rental growth, enhanced pharmacy sales and margin and good control of costs.
Group revenues up 19% to £48.3m (2008: £40.7m) equivalent to 42% annualised organic growth, it said. Pharmacy revenues were £26.7m (2008: £17.9m) with a gross margin of 30% (2008: 26%).
"The new financial year has started well and trading is ahead of last year and ahead of budget. I believe the company will deliver long term value for shareholders when the true potential of the GPCo business is realised," chief executive Richard Burrell said.